<SEC-DOCUMENT>0001193125-20-161340.txt : 20200605
<SEC-HEADER>0001193125-20-161340.hdr.sgml : 20200605
<ACCEPTANCE-DATETIME>20200605065041
ACCESSION NUMBER:		0001193125-20-161340
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20200605
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200605
DATE AS OF CHANGE:		20200605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDNAX, INC.
		CENTRAL INDEX KEY:			0000893949
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HOSPITALS [8060]
		IRS NUMBER:				263667538
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12111
		FILM NUMBER:		20944637

	BUSINESS ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323
		BUSINESS PHONE:		9543840175

	MAIL ADDRESS:	
		STREET 1:		1301 CONCORD TERRACE
		CITY:			SUNRISE
		STATE:			FL
		ZIP:			33323

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEDIATRIX MEDICAL GROUP INC
		DATE OF NAME CHANGE:	19950801
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d921216d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:md="http://www.mednax.com/20200605" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-06-05_to_2020-06-05">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-06-05_to_2020-06-05">0000893949</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="md-20200605.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-06-05_to_2020-06-05"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000893949</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-06-05</xbrli:startDate> <xbrli:endDate>2020-06-05</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:9pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-06-05_to_2020-06-05">8-K</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:9pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section 13 or 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of the Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:9pt">Date of Report (date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt:datemonthdayyearen">June 5, 2020</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0px;margin-top:9pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2020-06-05_to_2020-06-05">MEDNAX, INC.</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact Name of Registrant as Specified in Its Charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:9pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-06-05_to_2020-06-05">001-12111</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-06-05_to_2020-06-05">26-3667538</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or Other Jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of Incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:9pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-06-05_to_2020-06-05">1301 Concord Terrace</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-06-05_to_2020-06-05">Sunrise</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:stateprovnameen">Florida</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-06-05_to_2020-06-05">33323</ix:nonNumeric></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive office) (zip code)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:9pt">Registrant&#8217;s telephone number, including area code <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-06-05_to_2020-06-05">(954)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-06-05_to_2020-06-05">384-0175</ix:nonNumeric></p> <p style="font-family:Times New Roman;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:9pt">N/A</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Former name or former address, if changed since last report.)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:9pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">Securities registered pursuant to Section 12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:9pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-06-05_to_2020-06-05">Common Stock, par value $.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-06-05_to_2020-06-05">MD</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="font-family:Times New Roman;margin-left:0%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:9pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-06-05_to_2020-06-05" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:9pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;7.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Regulation FD Disclosure.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">MEDNAX, Inc., a Florida corporation (the &#8220;Company&#8221;), will host an investor conference call and webcast on Friday, June&#160;5, 2020, at 9:00 a.m. ET, to provide a business update. The conference call and webcast may be accessed in the &#8220;Investors&#8221; section of the Company&#8217;s website, www.mednax.com. A slide presentation to accompany the conference call and webcast, which may be used in whole or in part, and subject to modification, will be posted to the &#8220;Investors&#8221; section of the Company&#8217;s website at approximately 8:45 a.m. ET on June&#160;5, 2020. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;8.01&#32;</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Other Events.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">On June&#160;5, 2020, the Company issued a press release announcing a number of further steps it is taking as part of its aggressive transformational activity to position the Company for long-term, sustainable growth. One such step identified by the Company in the press release is the intent to change the Company&#8217;s name to its original name, Pediatrix Medical Group, Inc., subject to and following approval of the name change by the Company&#8217;s shareholders at the Company&#8217;s 2020 Annual Meeting of Shareholders on August&#160;11, 2020. A copy of the Company&#8217;s press release is attached as Exhibit&#160;99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Forward-Looking Statements </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">Certain statements and information in this Current Report on Form<span style="white-space:nowrap">&#160;8-K</span>&#160;may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section&#160;27A of the Securities Act and Section&#160;21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to the Company&#8217;s objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as &#8220;believe,&#8221; &#8220;hope,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions, and are based on assumptions and assessments made by the Company&#8217;s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this Current Report on Form<span style="white-space:nowrap">&#160;8-K</span>&#160;are made as of the date hereof, and the Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the Company&#8217;s most recent Annual Report on Form<span style="white-space:nowrap">&#160;10-K</span>&#160;and its Quarterly Reports on Form<span style="white-space:nowrap">&#160;10-Q,</span>&#160;including the sections entitled &#8220;Risk Factors&#8221;, as well the Company&#8217;s current reports on Form<span style="white-space:nowrap">&#160;8-K,</span>&#160;filed with the Securities and Exchange Commission, and include the impact of the <span style="white-space:nowrap">COVID-19</span> outbreak on the Company and its financial condition and results of operations; the effects of economic conditions on the Company&#8217;s business; the effects of the Affordable Care Act and potential changes thereto or a repeal thereof; the Company&#8217;s relationships with government-sponsored or funded healthcare programs, including Medicare and Medicaid, and with managed care organizations and commercial health insurance payors; the Company&#8217;s ability to comply with the terms of its debt financing arrangements; the impact of the divestiture of the Company&#8217;s anesthesiology medical group; whether the Company will be able to complete the divestiture of its radiology medical group and the terms of any such divestiture; the timing and contribution of future acquisitions; the effects of share repurchases; and the effects of the Company&#8217;s transformation initiatives, including its reorientation on, and growth strategy for, its pediatrics and obstetrics business. </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:18pt">Important Additional Information and Where You Can Find It </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:6pt">The Company, its directors and certain of its executive officers may be deemed to be participants in a solicitation of proxies from the Company&#8217;s shareholders at its 2020 Annual Meeting of Shareholders in connection with the matters to be considered at the 2020 Annual Meeting of Shareholders. Information regarding the Company&#8217;s directors and executive officers and their respective interests in the Company, by </p> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">security holdings or otherwise, will be set forth in the Company&#8217;s Definitive Proxy Statement for its 2020 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;), and reports filed by the Company and ownership forms filed by its directors and executive officers with the SEC. The Company will furnish its Definitive Proxy Statement for its 2020 Annual Meeting of Shareholders to shareholders entitled to vote at the meeting and will file a copy with the SEC. The Company urges its shareholders to carefully read the Definitive Proxy Statement for its 2020 Annual Meeting of Shareholders, and any other relevant documents filed by the Company with the SEC, when available because they will contain important information. Shareholders will be able to receive the proxy statement and other relevant documents free of charge at the SEC&#8217;s website at www.sec.gov or at www.mednax.com. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:justify;font-size:10pt;margin-bottom:0px;margin-top:6pt"></p> <p style="font-family:Times New Roman;text-align:justify;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(d)<span style="font-style:Italic">&#160;Exhibits</span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;text-decoration:underline;font-size:10pt;margin-bottom:0px;margin-top:24pt">Exhibit Index </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:5%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="2" style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Exhibit </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Number </p> </td>
<td style="white-space:nowrap;vertical-align:bottom;font-weight:bold;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:left;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:8pt;margin-bottom:0pt;margin-top:0pt;border-bottom:1pt solid #000000;display:inline-block">Description of Exhibit </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">99.1 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d921216dex991.htm">Press Release of MEDNAX, Inc. dated June&#160;5, 2020. </a> </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td>
<td style="height:8px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt">104 </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Cover Page Interactive Data File (embedded within the Inline XBRL document). </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;text-indent:4%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:0px;margin-right:auto">
<tr>
<td style="width:46%;"></td>
<td style="width:1%;"></td>
<td style="width:4%;"></td>
<td></td>
<td style="width:2%;"></td>
<td style="width:1%;"></td>
<td style="width:45%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">MEDNAX, INC. </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Date: June&#160;5, 2020 </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Stephen D. Farber </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Stephen D. Farber </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Chief Financial Officer </p> </td> </tr> </table> <div></div> <p style="margin-top:1em;margin-bottom:0em"></p>
 </div>
 </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d921216dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g921216g0605050400013.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR MORE INFORMATION: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charles Lynch </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Vice President, Strategy and Investor Relations
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">954-384-0175</FONT></FONT> ext. 5692 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>charles_lynch@mednax.com </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>FOR IMMEDIATE RELEASE
</U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDNAX Announces Significant Progress in Strategic Transformation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Company Intends to Return to Original Name, Pediatrix Medical Group; to Refocus as </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Dedicated Pediatrics&nbsp;&amp; Obstetrics Organization </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Announces Intent to Sell MEDNAX Radiology Solutions </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Repays Revolving Line of Credit and Provides Business Update </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>FORT LAUDERDALE, Fla.&#151;June 5, 2020&#151;</B>MEDNAX, Inc. (NYSE: MD), a leading health solutions partner specializing in prenatal, neonatal, pediatric,
and radiology services, today announced a number of further steps it is taking as part of its aggressive transformational activity to position the Company for long-term, sustainable growth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced, since 2018 MEDNAX has been conducting a comprehensive review of its businesses. In that time, the MEDNAX Board of Directors and
management team have taken decisive strategic and financial actions to position the Company for the future, including implementing significant operational improvements and efficiencies; leveraging the insights of leading consultants; selling
MedData; selling its American Anesthesiology medical group; and enhancing its organizational and leadership structure to align with a refocused business model. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The MEDNAX Board of Directors and management believe that continuing to implement the Company&#146;s strategic priorities and reorienting the Company as a
dedicated, streamlined pediatrics and obstetrics business will provide the greatest near- and long-term benefits for all of its stakeholders. Accordingly, MEDNAX intends to return to its original company name, Pediatrix Medical Group, Inc., pending
approval by the Company&#146;s shareholders at its 2020 annual meeting in August. The Company will continue trading under its current ticker symbol (NYSE: MD). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The initiatives we are outlining today signify our return to our roots as a leading provider of
women&#146;s and children&#146;s care, and are a culmination of our efforts to concentrate on our core practice areas and refine our strategy for growth and profitability,&#148; said Roger J. Medel, M.D., Chief Executive Officer of MEDNAX. &#147;As
Pediatrix Medical Group, we will become an organization wholly dedicated to women&#146;s and children&#146;s services, and one that will continue to drive innovations to improve the quality and experience of patient care for years to come.&#148;
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Return to </B><B><I>Pediatrix Medical Group</I></B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Today, clinicians affiliated with the Company&#146;s Pediatrix and Obstetrix medical groups care for more than 1&nbsp;million babies a year. These medical
groups represent the leading provider of specialty women&#146;s health services and pediatric care in the U.S., with a network of more than 2,200 physicians providing services across 17 subspecialty lines. Pediatrix- and Obstetrix-affiliated
clinicians care for nearly 25% of the country&#146;s NICU babies and make 1,900 maternal fetal medicine visits per day in over 400 facilities across 40 states and Puerto Rico. In 2019, the Company&#146;s Pediatrix and Obstetrix medical groups
generated approximately $1.8&nbsp;billion in revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX has been implementing a number of key strategic priorities to support its path forward and
has developed a plan to position Pediatrix Medical Group to drive sustained growth, which is based on: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Benefitting from proven leadership and a focused organizational model. </B>With unmatched experience over the
past 40+ years, and the ongoing benefits of its refocused organizational structure, the Company believes that the Pediatrix management team is well positioned to <FONT STYLE="white-space:nowrap">re-energize</FONT> the field and accelerate growth.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Retaining national and local reach.</B> With its extensive national footprint, the Pediatrix organization will
focus on leveraging its strong market position to build its organic growth pipeline. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Capitalizing on growth opportunities.</B> Women&#146;s and children&#146;s health services represent a large
addressable market and the Company believes Pediatrix is positioned to drive incremental growth through robust sales initiatives and targeted <FONT STYLE="white-space:nowrap">tuck-in</FONT> and strategic acquisitions. Additionally, the Company
believes it can generate additional growth via expansion into adjacent clinical services, as well as innovation in care delivery models supported by digital health, data and analytics, and genomics. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our Pediatrix&nbsp;&amp; Obstetrix medical groups have strengthened and evolved over the past few decades, and we have been steadfast in our unwavering
commitment to providing patients with </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the highest level of care,&#148; said Mack Hinson, M.D., President of MEDNAX&#146;s Pediatrix&nbsp;&amp; Obstetrix medical groups. &#147;We have cultivated the most talented group of pediatric
and obstetric healthcare providers in the country, and I am proud to see the Company turn its full focus towards the continued development of these important practice areas. We look forward to building on our strong foundation in women&#146;s and
children&#146;s health care, and we will continue to invest our resources and strategies to deliver the best patient care and experience possible.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intent to Sell MEDNAX Radiology Solutions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX today
confirmed that it has been reviewing strategic alternatives for its radiology medical group, MEDNAX Radiology Solutions. Prior to the onset of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, MEDNAX had been in advanced discussions to
divest this organization and plans to move forward with a divestiture, when market conditions are appropriate. MEDNAX intends to apply the proceeds from a sale of MEDNAX Radiology Solutions towards debt reduction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the Company&#146;s 2020 financial expectations that MEDNAX provided prior to the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic, MEDNAX Radiology Solutions was expected to contribute approximately $550&nbsp;million and $90&nbsp;million in revenue and Adjusted EBITDA, respectively, to the Company&#146;s operating results for the year. In accordance with GAAP
accounting, operating results for MEDNAX Radiology Solutions will continue to be reported as part of MEDNAX&#146;s continuing operations at this time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX does not intend to provide further public comments on this strategic alternatives process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MEDNAX Business Update </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, during
the 2020 second quarter to date, MEDNAX&#146;s operations have been significantly impacted by reductions in patient volumes and revenue as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. However, the Company&#146;s
operations began to normalize in an accelerating fashion during the month of May. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the Company&#146;s radiology services medical group, during the
month of April, study volumes declined by approximately 50&nbsp;percent versus the prior year. On a preliminary basis, the Company estimates that study volumes declined by approximately 30 to 35&nbsp;percent during the month of May, with those
declines lessening to approximately 25&nbsp;percent by the end of the month. In the Company&#146;s office-based women&#146;s and children&#146;s medical groups, during the month of April, patient volumes declined by approximately 25&nbsp;percent
versus the prior year. On a preliminary basis, the Company estimates that during the month of May, patient volumes declined by approximately 10 to 15&nbsp;percent versus the prior year, with those declines lessening to approximately 10&nbsp;percent
by the end of the month. Finally, the Company estimates that aggregate patient volumes in its hospital-based pediatric medical groups, including neonatology and neonatology-related services, pediatric intensive care, and other pediatric services,
experienced only minor, single-digit percentage declines through the months of April and May. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In total, the Company estimates that the reduction to consolidated revenue as a result of these declines in
patient volume during the month of May, as compared to the prior year, was in the range of approximately 10 to 15&nbsp;percent. During the month of April, the Company estimates that this impact was approximately 25&nbsp;percent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously announced, MEDNAX implemented a number of actions to preserve its financial flexibility and partially mitigate the significant impact of <FONT
STYLE="white-space:nowrap">COVID-19</FONT> on the Company. MEDNAX and its affiliated practices have also received, and expect to receive, certain funds available to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act
(the &#147;CARES Act&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, in recent weeks, following the divestiture of American Anesthesiology on May&nbsp;6, 2020, MEDNAX has taken
action to remove approximately $10&nbsp;million in annualized expenses, and the Company believes there are significant additional opportunities to reshape the cost structure of its support services to affiliated practices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Finally, during the month of May, MEDNAX repaid all borrowings on its revolving credit facility. As of May&nbsp;31, the Company&#146;s debt consisted solely
of $1.75&nbsp;billion in senior notes, and MEDNAX had total cash on hand of $90&nbsp;million, resulting in net debt of $1.66&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Our
highest priority during this challenging period has been to ensure that MEDNAX is able to support its clinicians in their mission to take great care of their patients,&#148; said Stephen D. Farber, Executive Vice President and Chief Financial
Officer. &#147;Our ability to maintain financial flexibility is key to meeting this priority. The steps we have taken, and will continue to take, demonstrate our commitment to retain a strong balance sheet with moderate leverage and meaningful
liquidity. Moreover, we believe these steps will help ensure that MEDNAX continues to meet its commitments to its patients, its affiliated physicians, and its hospital partners long into the future.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Conference Call Today </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc., will host an
investor conference call to discuss today&#146;s announcements at 9:00 a.m., ET today. The conference call Webcast may be accessed from the Company&#146;s Website, www.mednax.com. A telephone replay of the conference call will be available from 1:30
p.m. ET today through midnight ET June&nbsp;19, 2020 by dialing 866.207.1041, access Code 2325797. The replay will also be available at <U>www.mednax.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A slide presentation accompanying today&#146;s conference call will also be available on the Company&#146;s website at approximately 8:45 a.m., ET today. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Important Additional Information and Where You Can Find It </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc. (the &#147;Company&#148;), its directors and certain of its executive officers may be deemed to be participants in a solicitation of proxies from
the Company&#146;s shareholders at its 2020 Annual Meeting of Shareholders in connection with the matters to be considered at the 2020 Annual Meeting of Shareholders. Information regarding the Company&#146;s directors and executive officers and
their respective interests in the Company, by security holdings or otherwise, will be set forth in the Company&#146;s Definitive Proxy Statement for its 2020 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission
(the &#147;SEC&#148;), and reports filed by the Company and ownership forms filed by its directors and executive officers with the SEC. The Company will furnish its Definitive Proxy Statement for its 2020 Annual Meeting of Shareholders to
shareholders entitled to vote at the meeting and will file a copy with the SEC. The Company urges its shareholders to carefully read the Definitive Proxy Statement for its 2020 Annual Meeting of Shareholders, and any other relevant documents filed
by the Company with the SEC, when available because they will contain important information. Shareholders will be able to receive the proxy statement and other relevant documents free of charge at the SEC&#146;s website at www.sec.gov or at
<U>www.mednax.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ABOUT MEDNAX </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MEDNAX, Inc. is
a national health solutions partner comprised of the nation&#146;s leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality initiatives, consulting services, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and
today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,000 physicians in all 50 states and Puerto Rico. Additional information is available at <U>www.mednax.com</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, Section&nbsp;27A of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not
limited to, statements relating to the Company&#146;s objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or
anticipate will or may occur in the future. These statements are often characterized by terminology such as &#147;believe,&#148; &#147;hope,&#148; &#147;may,&#148; &#147;anticipate,&#148; &#147;should,&#148; &#147;intend,&#148; &#147;plan,&#148;
&#147;will,&#148; &#147;expect,&#148; &#147;estimate,&#148; &#147;project,&#148; &#147;positioned,&#148; &#147;strategy&#148; and similar expressions, and are based on assumptions and assessments made by the Company&#146;s management in light of
their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are
</I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
made as of the date hereof, and the Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking
statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are
described in the Company&#146;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and its Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> including the sections entitled &#147;Risk Factors&#148;,
as well the Company&#146;s current reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> filed with the Securities and Exchange Commission, and include the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> outbreak on the Company
and its financial condition and results of operations; the effects of economic conditions on the Company&#146;s business; the effects of the Affordable Care Act and potential changes thereto or a repeal thereof; the Company&#146;s relationships with
government-sponsored or funded healthcare programs, including Medicare and Medicaid, and with managed care organizations and commercial health insurance payors; the Company&#146;s ability to comply with the terms of its debt financing arrangements;
the impact of the divestiture of the Company&#146;s anesthesiology medical group; whether the Company will be able to complete the divestiture of its radiology medical group and the terms of any such divestiture; the timing and contribution of
future acquisitions; the effects of share repurchases; and the effects of the Company&#146;s transformation initiatives, including its reorientation on, and growth strategy for, its pediatrics and obstetrics business. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>md-20200605.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/5/2020 1:34:56 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:md="http://www.mednax.com/20200605"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.mednax.com/20200605"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="md-20200605_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="md-20200605_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>md-20200605_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/5/2020 1:34:56 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>md-20200605_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-4 Build:20200505.2 -->
<!-- Creation date: 6/5/2020 1:34:56 PM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="md-20200605.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g921216g0605050400013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g921216g0605050400013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !4 2D# 2(  A$! Q$!_\0
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MG KMY4<?,RQ_:^I_]!*]_P# A_\ &C^U]3_Z"5[_ .!#_P"-=?\ \*>\9_\
M/C;_ /@0*/\ A3WC/_GQM_\ P(%9^TI=T:>SJ]F<A_:^I_\ 02O?_ A_\:/[
M7U/_ *"5[_X$/_C77_\ "GO&?_/C;_\ @0*XW4;"XTO4KFPNU"W%O(8Y%!R
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M K.U#0=)U:99M0TZWN9$7:K2H&('7%80K-3YY:FTZ2<.2.A\=9'K7T=\$/\
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M,ZM@8XXZ\U;\0:T-#TX7"V[7$KN$CA0X+GDG\@"?PKFO!%QIRP:?;"74!?B
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M8RTCMT K-\9H[Z5:!$9B+^W)"C/&\4OBR"<P:??PPR3_ &"\2XDBC&69!D'
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LBB@!<T9HHH 2C-%% !1110 N:3-%% !FBBB@ S1110 N:2BB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d921216d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="md-20200605.xsd" xlink:type="simple"/>
    <context id="duration_2020-06-05_to_2020-06-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000893949</identifier>
        </entity>
        <period>
            <startDate>2020-06-05</startDate>
            <endDate>2020-06-05</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2020-06-05_to_2020-06-05">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-06-05_to_2020-06-05"
      id="Hidden_dei_EntityCentralIndexKey">0000893949</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-06-05_to_2020-06-05">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-06-05_to_2020-06-05">2020-06-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2020-06-05_to_2020-06-05">MEDNAX, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-06-05_to_2020-06-05">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-06-05_to_2020-06-05">001-12111</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-06-05_to_2020-06-05">26-3667538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-06-05_to_2020-06-05">1301 Concord Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-06-05_to_2020-06-05">Sunrise</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-06-05_to_2020-06-05">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-06-05_to_2020-06-05">33323</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-06-05_to_2020-06-05">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-06-05_to_2020-06-05">384-0175</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-06-05_to_2020-06-05">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-06-05_to_2020-06-05">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-06-05_to_2020-06-05">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-06-05_to_2020-06-05">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-06-05_to_2020-06-05">Common Stock, par value $.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-06-05_to_2020-06-05">MD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-06-05_to_2020-06-05">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-06-05_to_2020-06-05">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>8
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d921216d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d921216d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "md-20200605_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "md-20200605_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "md-20200605.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "md",
   "nsuri": "http://www.mednax.com/20200605",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d921216d8k.htm",
      "contextRef": "duration_2020-06-05_to_2020-06-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d921216d8k.htm",
      "contextRef": "duration_2020-06-05_to_2020-06-05",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d921216d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.mednax.com//20200605/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d921216d8k.htm">d921216d8k.htm</File>
    <File>d921216dex991.htm</File>
    <File>md-20200605.xsd</File>
    <File>md-20200605_lab.xml</File>
    <File>md-20200605_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M/_RNPFXT=F__L?%%4';PZR[D%U!+ P04    " !3-L50F5R<(Q &  "<)P
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M7V3\B.K%Q(40&9=_K3&'UOSH-U!+ P04    " !3-L50NJ$YBM<!   R!@
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MY];0\$'B<UCQ',SI;G\*+TWRL&6=-XJ<[O9GJ,6@WLX%][]$\0-02P,$%
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M2P$"% ,4    " !3-L50'R// \     3 @  "P              @ $
M7W)E;',O+G)E;'-02P$"% ,4    " !3-L50)^B'#H(   "Q    $
M        @ 'I    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( %,VQ5!F
MU/[][@   "L"   1              "  9D!  !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( %,VQ5"97)PC$ 8  )PG   3              "  ;8"
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 4S;%4%,ZH@VD @
ME L  !@              ( !]P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( %,VQ5 :4^T330(  .P%   4              "  =$+
M  !X;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0    ( %,VQ5"ZH3F*UP$
M #(&   -              "  5 .  !X;"]S='EL97,N>&UL4$L! A0#%
M  @ 4S;%4!9M(W]# 0  / (   \              ( !4A   'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( %,VQ5#_P"8(O0   (4"   :
M  "  <(1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M %,VQ5 +C]@#(0$  %<$   3              "  ;<2  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     *  H @ (   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-20-161340-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-161340-xbrl.zip
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M*[&2FEX+GB8-N0QW.LZ'.TBW+=(7YJO:.M V@(FR7_]^^3EKKJK;9TU;2M!
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M*'L0ZBPNEDRW A+MHAJ>+N<ZLS-'.)%->BQ_@8/?<A@:#2> ^<$3P6ZXA/?
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MBO3Z;;")YJQ)3J[K& AL= #R1K$$[R0EB2,\5-<DUT#:78/-Z(*,& 8=>,N
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MX*&GJSD<0*8+ -:&9NO/J?M'S W@6%9"G;2B/L4"- T@PT$Z>$E5R]PIE@Q
MF# "M:@W4QH]2Q8BB+#5R,36[?)@@GC0F==U\\BF[*X%!B.IF+E,3.FU,\DL
MTAUYQOI!<L-<QH9T_X+&2?X=QF#9X$PA121#]9J9YG4F1,-HCT/LTX%::X]-
M1*UJE@] "TF64D:L\%)AX+>%752OR+E<I6<9=<46)J8C]CIU$QQ]G3H)QW-C
M06"+QZE3 !$H?&SH@Q98VD1'9TLR:W3=+ A3L F C"3DEJDO,K&":QEPAM 2
MF<109V)PF4#5G&  IJ>+N ]=C-1K?\E7R<C;6)1\ECT,RUN:I-VY1% 50.9%
M4)VM;$BFT&/I*%:I%\>X6X=K85^ !2RR<I,NG:ZIY'6KQAOCJ<)BV=7)(%LH
M,R#'H#S3;:D<JYWN;0"C W+0NT]R#9?]1H7*9W2>#,S26"% CF,1<#G5?3T-
MF_09Z_QUBH?AP4UH%H],V<J\;T +TH(?RZ&FL+J:[%@@!$-B9&E4!#OC&#,2
ML!43-Y]*\CKWPC/?&F9@8?<&0XYG/PNZ0GKY2>@\$GSR#>6^AB0C9O(PG5[K
M^2=5/YZ&M%Q^V2PRN8QN,'/2BP>Z>(\S31.P7$I?1;A@&@)AD6B2RL9J:7G-
M+_<]>0U^U=*BY_LBW^LN\O6^C6T.IVE&=U6LI=O%CZ=:]?L]!@ ^7FP.P!Z&
M_=8<KF)W[DM!S8J/DWC;R]O@],_]H8)QW*1PD(AF\]V*:^QGUG<\2-5-%M_7
M!3G<5;:1Z#KZ]PE80HG^I27DZ<Z..9GU/N7AL?S7JM<_/;;JJ-CJDU^[=YX+
MZW6RQX\_& ;L027Y5.ND?'P3A\02U7K=(SCF:TR6B J!KLO))=*L)5BM6^=3
M[QL<AKC_?-;:A)=]X).H1"F4K2.*I6\IE94Z^;U0YG=M-49^Z'ZM'1[K8G>Z
M+%-4JE46F/-#%>>E;":W#Z[E#@9_0ZV>[JC8_5I3/(9SKWYLA&0>H<Q%LDJ:
MN)E*;Q+P]9:2A_N.'-7/XR=>Y(A5X3!+LXUUE#L/M)@F&_.:?*3$_((RK]=Q
M.LX>())>SVE.U4P?^)>27-I=0. (\AMK]7JE5[U/DAZ^^XIW7_$2OL)I[[R[
MBI=Q%0-<\",7H-=@_X *J:D^'U-%B?Y,]!8#U.=YMK9H2YE##2P(_A;/M&BS
MW5QV#UD*_5ZK?D"M^CE.Y%X-?SP[NO[Y\N3JE5::G$[Y%TF9PWU_Q%QD6]K6
MVKU7<2K0B_V%V4KBF0T^II!MB^02)F V0V&-=<2FU!\GY5&=^]L&N# 7![BM
M!+L#F4U#O4VM^1WF];GG:WX49F?O$5]Z6?^#,IW'C++[R+K!,W[^X=$K3*M"
MWVN$H=>>3%K2Z=:>=F)/75XN_L:MIT#*SMY:P/5M-GMS1HV_FJ^_G%BMQ+G_
MB<;^/IF7F,R[/WKW1V]7N[__R?Q]T?^FHT)Q!N@PJJ>X:K6B]$F.VF%+MLB5
M8A'N1#ENDE,J2NM,[\;W+>OK^V2^U<FL,JJ7&7TPY6Q,LCTWYV;SWXM4"3^V
M1J&W@ =3-?,/_Q]02P,$%     @ 4S;%4$X\W(,<&@  #UT  !$   !D.3(Q
M,C$V9&5X.3DQ+FAT;>U<6W/;R+%^9Q7_PY3V))74H6A2MFQ+EE6'DFA;B6PY
MDKR;/2^G0&!(SAH$& P@FOGUY^ON&=Q$RO9&=O+@;&I7Q&4N?>^O>W#TYN;M
MQ?'1F_'H[+C;.;HYO[D8'X__OGMPT!\>/9*?N/[(/:".3B[/?E4GKT\O+RZO
M7N[\\N;\9KQ#-U2W@^=.=9+K[/CH[/QG=7WSZ\7XY<[*1/G\\'E_WR0[*HC-
M+'FY$^MISF\=O?>/+8)L9I+=/%T>#I;Y"^5^3](\3Q=R:9HF^:XU_]2'P^KW
M-%B8>'UX8Q;:JG=ZI:[218"91A?GK]^]W,G,;(ZICDZ.QY_F9F)R13M31X].
MCH\>O3^N+: V^AY&;ZWGSG)VCO^83.SR!8V"C6_;Q]WW_,I")A51@2EW_O:U
MNKXZ?;DS.]@;[@V?S@9/!_OXY\E@,!@^[O^VG-&;-R]W+BY?7PKMFNNO3<P;
M^%<I>/SJ\DJ]O;P:J_-W^//MZ.;\\MVA^LQ^_^593^=!%N/2Q3H)Y_?L\4$F
M^]F$6KW/M#41N-%3UWD6Y'JV5D$2J?/D5ML\S=25CH/<I(DE1?BFZSEZ=?GN
MIE2<N<GUKET&H3Y,TE46++_@@8/])[N/GS_9'0R?[1\]HJ>/W7^4_I3WU?[3
M@[UOSL.C#\>AL/'_8F+C_RQTE 2?^F&ZP-P?VIKWX)*+^4EXS]^^'9^=CV[&
MZFI\,1Y=CXE_WWSVMG[#]& 9[T9_5Z,D28LDQ-/7L()F:L(@R2%^Z0P2:)5)
MO/R94-UD06*G:;9@R2OMU1:N?9N%GQ^?IHMED*RA"KE.(JOR%,J0%UE"?UW"
MMIHDB-6[8*%[ZKV.3)!GYI-ZB[]"7'^=I<7RA;PT3</"JL!B)^?W[>0A;7]M
M(V>\I%Q'Y3)#*_;[C\$":[R<V%SS56QK%B3FGY[N]Z[V6]&]DA2F?$XTO-9Q
MK)PD70612>,4ANHZC0NV3?^NI5[I9;"VX/!M&M^:9*8N3*)5.E6G&2B=LR6%
MB-_"PEIU4EC<A:Q_6$;@QG=9,RD@K,&-NAA].!M?G8TNQCWU*@[Z?_QIN#]\
M\9<"R]WOJ;W!WD"ND*X)G7L@?]A7?WKWZ_7X4+T]^W-/!2K6(#[V.==!G,^5
M+1FP#+(\T9FR2QT:!#K_I*>@U,M,)T$>Q#V5Z-3]M?12V.MVB$)9R5"KLUMX
M)=L#SZ. /)&(0H2IDV(QP00@[K3(\CG-E>LE+$>N#)0S^$@S!K(2>LKD4+D9
M6Q=SJU7>L"E0T"#,S:W)UR1>R]0:%GF,J[S>XV$5I\EL%]Q>])0M;!Y Y2>Q
M5K,L7>7S_GV^Y&'8-[)$P5N3%C:ND0.K,?@O^#9\[M5BCKU/M$Y4F"91@<T1
M.?!C@0'F.F$BT% 8W%%GX@12VSYXC;T'T#5#YHS(X(8]28,LHC?.3*9#1 26
MI+K;P?*"F5ZP?NI@@>F)R,%'+""""/!TMK3HQ.8IB)>0<##I26CNHSS]GA8P
MMU@.]AH7+'=FL8QY4OIA:XXD7>K,<Q8/0>?X,5ZLTE,\930FU_8%9/@6S\YH
M!)K$@#0(DRWMT8LW2&B+.,? >-["]N!BMP/3?@8)+J\P$4<+G=$2X. 0,,T1
M38DH+YP?F(D?X&4D<R* >S&MF5JB"1Z@Z75FYV9)I ,/L7LB$B<.:F6@<0%X
MR.X$.N'YIQ9II./O((TWGQ,+59.*B8Z-)ID@L0)!P;*":9Y67*QS'?;GR=,7
MMB8TR\RD&:1#R]B9QB_'^KJT0.Z#;B?R3JY'(T BP2'0J+0U,D9:N;J2>BL#
MW[(4*\T#PV9@()O#9 79KG#&VP%L*]%3XA\):8 WG3)9DOUY&A,#^VH4AFE&
MHA2O>YYDIHHCLC*.$$EPL43H=I3<%U.(728KFD0LEL&2%H_;D_5&>B(8]0M3
M8 7-2/:>K$F!MQ9:Y\Y8CXH9C%Q?W=2HR]1Q[&,KR@I2)!B.APJ++&-.FO C
MV>3U8I+&-:]1BN4CI,7P=RY)1@K'_S\B45_'NBFM>G%'6.G2$K*U.P%W/NY.
MH 69/@SB%1PP981';Z[4]?G_0NP?[_@A.4\__.F _[>C?CD_NWGS<F<X&/RA
M=.:GXW<WXZO_Q"3^F!CX[,4-FRAH 0P%4C*UT@K\5&F10\!%G\A3BBU<XWI6
MDR[^E:8Y!Y^5]W;"3LZTVUFET$0O+"3KX=S$459="P.RP72')H9+*>(%Q)6M
M-H2?YH"!3;.<11NB0@$2Z;"B!W 7JJ Q)UG]D%<?>(6><KA49%[IQ?2+=^5'
ML%(H6S Q,3QUCU;T'.8W,!&(-,,&_M(GY= (*M[VSZ 4IW.CIVK\28<%D4M=
MDN67J$&TL*^$K"/DLUL5##1FL9]H:"16G#2,M5I!F^"-2XM#V_XL%:O0ANU0
MX@QC2[U2%66T;@-/?QN47M)Y-%;O?T!I*6QAC_();H\<&P>=2[Q JD@,8T*N
M8;\<4Q:Z+]2[+XT?/G^@D+/*DSAW.Z%8>0NU)0KFASZ7Z#U]$!]&ZM)3(6D/
M@A'0-X",Q(89R2YV@PVMUDY4]_G2IZ:3MQ7A%R3QX&^BAI)H82TQB<X$HDSN
MC%G#AM9J/TJWXX;)-$(VZ]WC!J7U43:DH"%W/BIWHB8:Y!V@K,Y(I/6A?PUM
M<1%%HO-5FGVD@:N%[_7V!@.UG*^M(Y/,SW%7.7Z8I7"@PV<(CB?5FLCSP@>6
M1-MM4FVW(GBW4^-#23URN]"OO?T_T))HN2'"WCPKV?'N_/1#24J..CYJ->P=
M8,$([W5&OG2J<W9N("T9F5M$I#!04!=%YA)D@#YEZ@E>F08AF1=3;>C)@-QY
M[D9_7^B,TG@3IAPG(^@^Z/U^*0&;$4)D+&_LNC\96C0V_%_#_G,1EXD3%RP3
M(;N&:>A_<\2SG48T0NUZ^O51KS<':2"2+99+> *.#&".YL3/%46*G#/0V!'V
M$R-:IY1N&0=)(PG88B,JN^B2,+PM3@(R/#?AG#+ 24 Q<9H<MBE54>'I5T+;
M%)_<C$XNQGZHD\LK9-&[B"LN1N\1X/@_[B5MFP\[2H9YN3/84:?CBXOWH[.S
M\W>OR]_7[T>G_G<]9I'U7$ETHUZJG5H\1%E,A'CH-C61>_#,O[S_AVI3-V>M
MFX\1"_WL@B$0I0R,), AT3[8]-JP]=J&">H#-9\EYC3N.O*J)G/4=J'^0DJ3
M5SF1@)W%>)JE"S9DD.]:LL6QC?)I52LQ*Y.KD^-?R%X6"=0UG.NF]R5C I/0
M[2P#) Y/!O\MSE>\/=D*)! I+:','US>4*5SK7G+#+!A:WQ:95VZCCN5TK1S
M<D/A(B4W3K\D5/DLC)[I7;)0,Y#1P^><C1L=1T*K,-0QFS"/A$A4P=S'OZ[H
M7Z0W/]3PAQHZ-41(&$C"DC0@CY2L/&@7SOND8HIUC!1#?\H=:E6^,$4J W]#
MQ:JFX#?#<SC/;D<P]S2IPSV2IV=01=K11YW7X*=430I$[#5H)O2)R-(L-<4T
MXH-_"/D/(=\FY*?!$MFJ0[\A54Z 4@Z*BH3#)"?FG\L7V[%\E10@C\=*X6J"
M*")TFQ%I)\_>V]SQ%I6NP"DT_8'/.,.,78<$JBM.A!!\S>8J2R<(NY!V4VFZ
MCD7P;+06BF4_ZU;R(B39\2Z%7JX!Q.$_"B.K(O@LBHSH/.%GM0UU.^6.#"6Z
M(+$+IE50ON/7?VL"\M'(+226)B0U^BT(.4?FO(/<;)67.V\9V%KZ32$X)R8(
M K#G;"WQ@/61+L&P:Q69&?'=,:V'%",/Q%-B.>O<A"X0P&+3!7YMLR3?%+T5
MX..RR"IAV%0%O)/5,K)/F&HR R=(:!AZH)(712TN\E$<^$PQ7:1#1%9NQRLM
M[W-*@0F":$K/&4&&BF2%FQG#F&&Z6)A\X0I^5;;I4 TKV>H/,/'W,;_;(1[-
MS6Q.P#;Y1$:N&=NKPVIO@_"C>@,+GR8>4RM;1"H4[4[&^R6"Y*&W7YQ(A$4,
M,R( &M:V2+$P*!&1+))7&-3R^(74"DL W^D:ZZ:'1JR'-QQ>(")XK@(.^@NV
M=E;KAH5DH(KQ_"*.)0? 8Y2S6C>48'.1SUP7CA(Y8S?(DF$%J +5!#C["MN,
MT_1CF0'[",.Y!H=Z4BPRQ6JCTMJTD41HQF;74.&R'J^LXXB&&W@<'FSQ'P\(
M>9LK";LS:[S5";W0 !%;&"/\AC7P-@Y*O+?@]%!0XM?T -QI:WMH\-#-SI [
M6:QD:K(%RR\75BKP1 JM#)95+BYF:$I<)^%<G/Z5&VDH2^^>C?:AD88JI*E+
M+*WV OEY)WQZ^?/YV>[PP'MAZ$"DX9)Z51DY<OA/ F]Y&W#U/3(6>F$='-WM
M1(:%*Y^;9AU3$,<X$-1Z09"U%W^'-<J;1O+:%=R)CURH:BWN7\H,A(PAU@?M
M^AL*:+@=2[4+CX5:XRKG]@%'*96AVB@H7KTC/<G!*2Z6I\EWJN:[[H0-\"$7
MY:HB.>E=F/L:  F8VY*S=I% ;UX,8(A@?WZO'!!NT1*$391;!=:M2T)',CB9
MF12Y;D.9^_N#)O)-DO%?!ZV+%;[)]T?1;P@T,?3XY/SF;-0CRT63068X#DPW
MD<U5_J%J>!HNQ9;M X*QGR>$5Z191*(L8OAZ-'H/=Q*RF\";O2V#W$>)MKV=
M4'>%BPAK72A-?UDK@Y<-"UR494VBWHOO((5N5U&*RTF:.[6J@BY=-M@LBTE,
MA0-$9AR!<9N&L=ML&JNBM?=OX:'\@N]#N--4]<V=0+,GATQCG%KJ.X@*B61)
M]EB9K2:K1A4[B 5K*JVQUQ**FB340N6JMP63B')+KE$:+(YVO+M&-%XLRD8)
MIU*6VT5(GO]E_]!7;](5(2F;*A_=3FT/$ST35#^A9BODPEQT"I(*-60D-K!S
ML@!",Q< )I0K0V>"];<O=YPGFXS)W5:TME^N%MSME"L>P13'U'A21.N2%<B#
MI <%3&M:1V\;031.1D%66UCGSHPKW/;594(UD@P1&M7;D7I. FML$PXF9[K@
M4A6[B"]=P>,!<>CQ?G,=6YC1\W51B#DUVO"@%DF$M=JU(+2&WVL-[#I3R,PX
M0>3Q7=O979/.5?M=J>A\MK+>S#)Z&W?A&-36ENT$:NV@VWDX'FVE\I>O;LCL
M&^Y_@1C5F:>^A'?#06OG6YGWRMP%:-J;Y0[,&5GF]NZ,I%U8%V-FCMM5N;K-
MUJH)4#I)14U)(&J_=S,ZKH!Q*EBG&I$='2/*5>J4BJ,KGRG?ZW:JQ(?*BJ ,
M.)QFW'HYB_4N8S[*42F8U8CK<;.25+8409ZSM&\_@(S?9[=3;B.^1^KH5NDG
M7:!JT]A$+!O;_6-=14Q"07%=9K=K;F"E=R^3L/B.!@8E,I$%R8SSDR]0Z+XZ
MVV[*[MT]8C27#]#4]UJV?V<3L\_K?*=!J\^[WB9,V'=&,#6%YF6.-(WU)R/-
M89)Z(M R9).@J[EALT-TJC<*5WF2Q$+=SE=$0\T^Y3(QI:FYW;SJ)/)HD(OI
M@MA2UV>H87VB7HFKA+ET@_+UG@IU1D4RQ-^4Y@:W@8D9W,<S&]$NZ<*4%66P
M@;<F@_T?&<QP13#Y5&8:0_H)=E;7.H1 @5:C$';]3_2B0'*GHZOQ-5T58.?/
MWS[\:B+\G >R#UMI_1%&>YK&<;KRLE\##5@#MK1<@SO01I'NIW*HH5?OCN?N
M=,K[O%7(-$,4[2Z<NTFJM,IB:\*VQ.I:97]#95YGTJ59%[Q:?:)1#Y*%V'FP
MU YPI%I+V?[MVXM=8TT9EI+?WB!NWT&=2[>_U1PZFB,?)DB9FJ0G:98Q/SF)
ME+X'?V8FE+,RK@T+6C6R;B3AP^/AQFXK1F_(KAN&#&#>P3UD(E/JHWJV?Z>1
MBN(=:BY+<\^\&N+%+@5A@9W3^N:!Q#IMO*+GO(5KETYT+JN0.9\^;<SY[76H
M+.AT.Q[8=]U8ZXHW< 7A'"S0"9? *:1)HPJHA!A!G(M,-R FO.0-3[VCJ]:L
M)^[,9#"TC NRVZ,V/&Z>%_18?"J>\26<1J7A.M=+PO_.$$@&V80RRZIOMWDV
ME;DEK;VOO.WO=EQOKR\K4&'+-0HS^ A#*L9TH[? #JF/C1YT_>],*D\_Z8&7
M T:^A,7FPP'N;?2'[D$A8$\2ZWJ?N?&Y7M+*N ."($J!_2=!S)"4G6,%$J53
M;9'?=DT+ HLM=$"A^K3 IF/SC\)$O,*W"/52SLA7NG;:@H(8MW!:Y5S'RTTL
M]JNWG@;"X7+%UI].*)EWQ\65O:&]T@/Z:-Z?![-\<D)JK]6)GN]9/SA-DRG,
M,1'ZE"P1]_]^OUJ!/ZTAO"#3'L %&7^Z.JQ6%]+J""(2K%V*#%7>*T&3.].4
MJX/#P4 %_06&'M_(LR*S[1%_T9.0*JZ+@#P4@S"6$BV&RS>853QO#8%4J]6J
M7QU=AE56<(]066I=AV6/,5[9G=N<TO7.UP(8GFQX^'B D!IK+I=<IDH+$R5T
M"HONT*%$L:349\M &I?8 SYS]?SIT_[>X%E_.'@"OR#;P1XBK?8>[^T_.W@F
M9' KY*5P\-58#PAX].&XN4,Z'?T]@F%E8\)873>'*YN$[NA/>:"CAAC?I>W=
M#:4;<925\)*VVXQQGA\^V;\C/3\RTM]?I"RKP%5<"\6OCK"3??R%P\)?TP*&
M*"%'%JGS_+N<>6@>Z*V%_96X(.@7 Q\USO/YC,1%H;ITT +1X2EG5R*M%Y+\
M3K2D8:%9TOE))2X/R7=H\O+0$ NCEJ*= .9?>FIM)*?6WCJOC;&NZX\:/O^:
MZ-"U KKS'&!#KN4LS$1+U(C'*=\4L. +ANXW&$J@%A_PVQB:-FBX@6A<UI?8
MJ"IQ,3Z%GWD)%KAA>V3_K,_=:#D22&>"7JV,U;W2Z%(QF YCS5N#^+6=T:$K
MP_.]!Q/6B,-@$SA&\37I+R!&SU$2P4#]V(Q+,/VYC/$GA)Z$=YQ26,%Q8B/M
MO!Z?EK(GA8LE'R.349O'&06M6R6N99LX47OPKN1NH'JUS/'IAD..TR)+C)7F
MTX>A$M?*&Y),QRGR6!3E-A73S/+I!BB#2]H9']]>KN]9=Y'-N!.NI2\$>.$G
M=;10O2B0//6A."]];6L'G68("F[)\D5I6$AXPEPI<>.*QM4N7.F_\E\3'0:%
MY?"U=N24+$_58&,J]>LWR5P&'"YG<8"*[P_XM);C/ N?2FQ?>:8Y;:$/N,Q*
MYC@Q;7E4BAZ@E/U9>DNJ&.2PX-MCBF]\X&YT<OGAQH?VWSFX12[5[015E_;6
M;T/PMP@,'W60P%%>\;1M'W1C%*!,,DKDHZ_>5X?26!9]EXJ (-S8FED/B;2^
M"N$1NTP[T*7$F'Q_I^N*8WDMLUQ_N,U9-FAU=>#-$)Y 9>B9TK3PI"Q=Y6D:
MXYY+M=+"EH<W:UVT/?^U@?K1NE[5H$IQ8I"%<AZ60O#R3!OG[G/.(3U0G18Y
MG?6T_O LE_,)'-AU,_<87]K5TZES.K37EC$,K+2D80<@P/#@V4'/>2PY.^F#
M]CN09SK5;.3Y*'L&O962<*_5N6)K*)8;:LLAQ,>]0?,0(@43T/7][0?T:@%8
MS6 PHO&?$/[3=X5<3%7:)-E%8[6)AR,HNR%#%= YT7:HY6VDZ[':I7Y#Z3DK
M1ZZDV,,(7OG>9]Q\6?/9W<Z%H.:T!/IJ4;8@3)A>&!X<[/?H45983L[VGHW\
M4#6W7S[_^#&710(L@P2I[O4;3S<"@.8$P_&&"<J8HIKI27VFOGJUG1H+/OI)
M=41$3),B9SN0I#GA*@LC34V]^@M<3G1ETDV%ZLEOHD949XR]0:HZ+)VSC./:
MF#WG?EC :U-A+V YXA?6^BF,%Y>1 T:.60[<%VMX7"IA\4F5>ENJJ_^LM.OI
MZ;DB0X\T[S?^P^-$:4;]M!*EYZY]E XN4U8?@M@^>G2 C3NI7!=9!OAR^MX,
MG"5UIV2,CY/7UQF52J6-HB#+91WKW>P>!Y2+\W39NH)5-"]4*VU>M_.TB*/F
M-;?UQC7B3<^??Y=+M./F0XY6S6NNLM8:SE&S>;$\5-%:H_NT@;O( @)ABX.,
MN).)Q;35!Q;\.590S1:+I6L1HYOTI1[K!1EV??/W/FJ' ,'#F%$5^LZ#.+):
M-Z^K7Q ^2Z7 I<_-:E)(3?\1.2/WD8^J2;-7]0&*B#3EL(JR2) I)N?(KD0I
M!;ZH]WB.Y+L_VS1WLT4$O0BQ*+^C]0.[^'IW1)]RBK@8[HPM]]$15I%.[Q:Y
MN.1(:#?U#JJH$+"]D.:[-./&9V),XE2_;O<0\[-(M.KN"993<WX]+U"5B2O3
MW#O&'8%8TR110^.L@$$"A;65KX7Q:)!QGL)+/I?G"K;?G#(8^U'$EF!6=M!\
M6$M5T$XER?Q!(Q@>)4D+KA<2J%'G:*^A"4+!\EM#\FDL5]2.#**P3#Y9(%5K
MQDGOT0*6=P10868F$IUM,@"$,KMRJLOEKCBQ)J/RBISZ9[L AX/=O];/:5&D
M]S?I8L0JKUR:_C7#_:WGQZOZ>+@TKUV1O\R,Q6I>@1_JE5!<+"=]+,Z=T-JP
M:6^ALJ]=V_/=OY9+^VHTPQ4^)*)X@#9LBM_9]K0 73G[TNQ]*&VQ@TZD;9D^
MR%/V8KZ0QBV.]?F6]IT M6[[S="QE]@[0]#/$7WN)^)0^I3TB$(Q3CA2.JO!
MBV-*N5(X?8@H8Y5?ZB"6:^GTQ<;^2_^UV;E92O#:[<RHR)60 H!XU,>3\6%Y
M[I+ 7\W.B%D6+!K-8O(A"7>617Z8R%?QJ.3&[C)R%<O:608'@%+O<\8$=WFM
MH5J:2[K6D,Z-^Z@5(BGKC6OP!T5'Y>E_+A\[GE*BFG%_$"O["\%%FP+5ZH38
M-/.]GZ'S)K@)S#31$UZP=JTSK0GO.;)2NHIR@Z43J TBU,JI6W+F".R.$$CT
MT>TX>UT_$'I'"!GM(GDJD!@C$+ ORME;HMJB3O,KD,TTO/:508[\Y6MS#K)V
MJNY.EM8_5R6P^>>_,]?_MWRD]*>??KJGL'/TB+YHCHO\(?3_!U!+ P04
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M.R[UEOD-&.DNFOP>"+WG/U!+ P04    " !3-L509\NL K0$  #_*@  $P
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M9H_]LN\A8LG?4$L! A0#%     @ 4S;%4#EC-IA?%@  Z8H   X
M     ( !     &0Y,C$R,39D.&LN:'1M4$L! A0#%     @ 4S;%4$X\W(,<
M&@  #UT  !$              ( !BQ8  &0Y,C$R,39D97@Y.3$N:'1M4$L!
M A0#%     @ 4S;%4+BRP99? P  &0P   \              ( !UC   &UD
M+3(P,C P-C U+GAS9%!+ 0(4 Q0    ( %,VQ5!V^W3+8 8  $=$   3
M          "  6(T  !M9"TR,#(P,#8P-5]L86(N>&UL4$L! A0#%     @
M4S;%4&?+K *T!   _RH  !,              ( !\SH  &UD+3(P,C P-C U
>7W!R92YX;6Q02P4&      4 !0 Z 0  V#\

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6628278096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 05, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000893949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  05,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDNAX, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3667538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1301 Concord Terrace<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Sunrise<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(954)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">384-0175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
